Additional Long-Term Follow-up for Subjects Implanted With a CyPass® Micro-Stent
Completed · Not applicable
Conditions studied: Primary Open Angle Glaucoma, Cataract
In brief
The purpose of this study is to assess long-term (10 years post-CyPass implantation) status of the corneal endothelium in subjects who were implanted with the CyPass Micro-Stent in the COMPASS trial.
Key facts
- Study ID
- NCT04629521
- Run by
- Alcon Research
- People needed
- 54
- Starts
- 2020-12-21
- Expected to finish
- 2023-04-05
- Last updated by the study team
- 2024-04-26
Who can join
Age: 45 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Eye Physicians and Surgeons of Arizona — Glendale, Arizona, United States
- Coastal Vision Medical Group — Orange, California, United States
- Eye Center of Northern Colorado, PC — Fort Collins, Colorado, United States
- Cape Coral Eye Center — Cape Coral, Florida, United States
- Jones Eye Center PC — Sioux City, Iowa, United States
- Ophthalmology Associates — St Louis, Missouri, United States
- Eye Associates and SurgiCenter of Vineland — Vineland, New Jersey, United States
- Cincinnati Eye Institute — Cincinnati, Ohio, United States
- Associates In Ophthalmology Ltd. — West Mifflin, Pennsylvania, United States
- University Eye Specialists — Maryville, Tennessee, United States
- The Vanderbilt Eye Institute — Nashville, Tennessee, United States
- Ophthalmology Associates — Fort Worth, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.